Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.
Sadanori OkadaTakeshi MorimotoHisao OgawaMio SakumaChisa MatsumotoHirofumi SoejimaMasafumi NakayamaNaofumi DoiHideaki JinnouchiMasako WakiIzuru MasudaYoshihiko Saitonull nullPublished in: Diabetes care (2018)
Low-dose aspirin did not reduce cancer incidence in Japanese patients with type 2 diabetes.